Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine (Q72534256)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126286%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126286%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

G. Holdstock

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6126286

10 August 2023

B. F. Chastenay

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6126286

10 August 2023

E. L. Krawitt

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6126286

10 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6126286

10 August 2023

publication date

1 June 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126286%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

27 October 2019

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6126286/?tool=EBI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6126286

Clinical and Experimental Immunology

10 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126286%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126286%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126286%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

619-624

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126286%20AND%20SRC:MED&resulttype=core&format=json

The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients

27 October 2019

cites work

1 reference

12 December 2020

Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease

1 reference

12 December 2020

Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors

1 reference

12 December 2020

Immunological aspects of inflammatory bowel disease

1 reference

12 December 2020

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine

1 reference

12 December 2020

Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)

1 reference

12 December 2020

Effects of sulfasalazine on selected lymphocyte subpopulationsin vivo andin vitro

1 reference

12 December 2020

Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization

1 reference

12 December 2020

Concanavalin A-induced suppressor cell activity opposing effects of hydrocortisone

1 reference

12 December 2020

Subpopulations of human T lymphocytes. IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis

1 reference

12 December 2020

Aetiological theories of inflammatory bowel disease

1 reference

12 December 2020

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease

1 reference

12 December 2020

Alteration in T lymphocyte subpopulations in inflammatory bowel disease

1 reference

12 December 2020

Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma)

1 reference

12 December 2020

The induction of suppressor T cells by concanavalin A is independent of cellular proliferation and protein synthesis

1 reference

12 December 2020

Relationship between T cell subpopulations and the mitogen responsiveness and suppressor cell function of peripheral blood mononuclear cells in normal individuals

1 reference

12 December 2020

Covert suppressor T cells in Crohn's disease

1 reference

12 December 2020

Immune regulation and HLA types in chronic hepatitis

1 reference

12 December 2020

T-lymphocyte subpopulations in the peripheral blood of patients with Crohn's disease

1 reference

12 December 2020

Identifiers

PMC publication ID

1536615

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6126286

10 August 2023

1 reference